EV/EBITDA
-383.28
+4.81+1.24%
Fri, 29 Nov 2024 21:05:47 GMT
Summary:
Alnylam Pharmaceuticals EV/EBITDA is currently -383.28, with a rise of +4.81 (+1.24%) during the most recent trading day. Over the past year, it has dropped by -310.12 (-423.89%). ALNY EV/EBITDA is now -270.11% below its all-time high of 225.31.ALNY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +1.2% |
3 m3 months | -272.2% |
6 m6 months | -101.1% |
ytdytd | -252.9% |
1 y1 year | -423.9% |
5 y5 years | -2159.9% |
ALNY EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -351.41 | -9.1% | -434.71 | +11.8% |
3 m | 3 months | 222.62 | -272.2% | -434.71 | +11.8% |
6 m | 6 months | 225.31 | -270.1% | -434.71 | +11.8% |
1 y | 1 year | 225.31 | -270.1% | -434.71 | +11.8% |
3 y | 3 years | 225.31 | -270.1% | -434.71 | +11.8% |
5 y | 5 years | 225.31 | -270.1% | -434.71 | +11.8% |
alltime | all time | 225.31 | -270.1% | -434.71 | +11.8% |
Alnylam Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2024 | -383.28(+252.9%) |
2023 | -108.62(+227.8%) |
2022 | -33.14(-0.2%) |
2021 | -33.19(+52.5%) |
2020 | -21.76(+43.9%) |
2019 | -15.12(+61.4%) |
2018 | -9.37(-62.0%) |
2017 | -24.68(+218.5%) |
2016 | -7.75(-72.6%) |
2015 | -28.27(-34.3%) |
Date | Value |
---|---|
2014 | -43.03(-12.0%) |
2013 | -48.91(+194.3%) |
2012 | -16.62(+197.3%) |
2011 | -5.59(-36.8%) |
2010 | -8.84(-39.5%) |
2009 | -14.62(-66.8%) |
2008 | -43.97(+203.5%) |
2007 | -14.49(-23.3%) |
2006 | -18.89(+119.9%) |
2005 | -8.59(+79.7%) |
2004 | -4.78 |
FAQ
- What is Alnylam Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Alnylam Pharmaceuticals?
- What is ALNY EV/EBITDA year-to-date change?
- What is Alnylam Pharmaceuticals EV/EBITDA year-on-year change?
What is Alnylam Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ALNY is -383.28
What is the all time high EV/EBITDA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high EV/EBITDA is 225.31
What is ALNY EV/EBITDA year-to-date change?
Alnylam Pharmaceuticals EV/EBITDA has changed by -274.66 (-252.86%) since the beginning of the year
What is Alnylam Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ALNY EV/EBITDA has changed by -310.12 (-423.89%)